Senior Director

Maryam Yavartanoo, Ph.D. is a scientist and founder specializing in AI-driven drug discovery, systems biology, and translational medicine. She currently serves as Senior Director and Board Member at NetTargets (Daejeon, South Korea), where she leads research strategies integrating artificial intelligence, multi-omics data, and mechanistic modeling for drug discovery and age-related disease research. Dr. Yavartanoo received her Ph.D. in Bio and Brain Sciences from KAIST, with prior training at Seoul National University and Tehran University of Medical Sciences. Her research spans genomics, epigenomics, tumor immunogenicity, and computational target discovery, with publications in Nature, Nature Genetics, Genome Biology, and International Journal of Molecular Sciences. She is the lead inventor of a granted patent on virtual time-series generation and ODE-based modeling for identifying drug and cell therapy targets. Her work bridges academic research, AI platform development, and industrial translation through global collaborations with biotech and pharmaceutical partners.